The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome

Journal of Investigative Surgery

Volumn 19, Issue 4, 2006, Pages 255-265

  Flierl, Michael ^a   Schreiber, Heike ^a   Huber Lang, Markus ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

C5a; C5aR; C5L2; Complement; MODS; Sepsis; SIRS

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT INHIBITOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOMODULATING AGENT; MONOCLONAL ANTIBODY;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; CELL FUNCTION; CLINICAL TRIAL; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HUMAN; INFLAMMATION; INNATE IMMUNITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C5A; HUMANS; MULTIPLE ORGAN FAILURE; RATS; RECEPTOR, ANAPHYLATOXIN C5A; SEPSIS; SIGNAL TRANSDUCTION; SYNDROME;

EID: 33746294701     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930600778263     Document Type: Review

References (87)

1. Angus, D and Linde-Zwirble, W and Lidicker, J and Clermont, G and Carcillo, J and Pinsky, M. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care Crit Care Med, 29, pp. 1303-1310. [INFOTRIEVE] [CSA]
2. Martin, G and Mannino, D and Eaton, S and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med, 348, pp. 1546-1554. [INFOTRIEVE] [CSA] [CROSSREF]
3. Bone, R and Fisher, C, Jr. and Clemmer, T and Slotman, G and Metz, C and Balk, R. (1989) Sepsis syndrome: A valid clinical entity. Methylprednisolone Severe Sepsis Study Group Crit Care Med, 17, pp. 389-393. [INFOTRIEVE] [CSA]
4. Goris, R and te Boekhorst, T and Nuytinck, J and Gimbrere, J. (1985) Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg, 120, pp. 1109-1115. [INFOTRIEVE] [CSA]
5. Nuytinck, H and Offermans, X and Kubat, K and Goris, J. (1988) Whole-body inflammation in trauma patients. An autopsy study Arch Surg, 123, pp. 1519-1524. [INFOTRIEVE] [CSA]
6. Bone, R and Sprung, C and Sibbald, W. (1992) Definitions for sepsis and organ failure Crit Care Med, 20, pp. 724-726. [INFOTRIEVE] [CSA]
7. Bone, R and Balk, R and Cerra, F and et al. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. In [pp. 1644-1655]. Chest
8. Guo, R and Ward, P. (2005) Role of C5a in inflammatory responses Annu Rev Immunol, 23, pp. 821-852. [INFOTRIEVE] [CSA] [CROSSREF]
9. Riedemann, N and Guo, R and Ward, P. (2003) The enigma of sepsis J Clin Invest, 112, pp. 460-467. [INFOTRIEVE] [CSA] [CROSSREF]
10. Ward, P. (2004) The dark side of C5a in sepsis Nat Rev Immunol, 4, pp. 133-142. [INFOTRIEVE] [CSA] [CROSSREF]
11. Muller-Eberhard, H. (1988) Molecular organization and function of the complement system Annu Rev Biochem, 57, pp. 321-347. [INFOTRIEVE] [CSA] [CROSSREF]
12. Reid, K and Porter, R. (1981) The proteolytic activation systems of complement Annu Rev Biochem, 50, pp. 433-464. [INFOTRIEVE] [CSA] [CROSSREF]
13. Fujita, T. (2002) Evolution of the lectin-complement pathway and its role in innate immunity Nat Rev Immunol, 2, pp. 346-353. [INFOTRIEVE] [CSA] [CROSSREF]
14. Dempsey, P and Vaidya, S and Cheng, G. (2003) The art of war: Innate and adaptive immune responses Cell Mol Life Sci, 60, pp. 2604-2621. [INFOTRIEVE] [CSA] [CROSSREF]
15. Huber-Lang, M and Younkin, E and Sarma, J and et al. (2002) Generation of C5a by phagocytic cells Am J Pathol, 161, pp. 1849-1859. [INFOTRIEVE] [CSA]
16. Gerard, C. (2003) Complement C5a in the sepsis syndrome - Too much of a good thing? N Engl J Med, 348, pp. 167-169. [INFOTRIEVE] [CSA] [CROSSREF]
17. Smedegard, G and Cui, L and Hugli, T. (1989) Endotoxin-induced shock in the rat. A role for C5a Am J Pathol, 135, pp. 489-497. [INFOTRIEVE] [CSA]
18. Czermak, B and Sarma, V and Pierson, C and et al. (1999) Protective effects of C5a blockade in sepsis Nat Med, 5, pp. 788-792. [INFOTRIEVE] [CSA] [CROSSREF]
19. Huber-Lang, M and Riedeman, N and Sarma, J and et al. (2002) Protection of innate immunity by C5aR antagonist in septic mice FASEB J, 16, pp. 1567-1574. [INFOTRIEVE] [CSA] [CROSSREF]
20. Huber-Lang, M and Sarma, J and McGuire, S and et al. (2001) Protective effects of anti-C5a peptide antibodies in experimental sepsis FASEB J, 15, pp. 568-570. [INFOTRIEVE] [CSA]
21. Huber-Lang, M and Sarma, V and Lu, K and et al. (2001) Role of C5a in multiorgan failure during sepsis J Immunol, 166, pp. 1193-1199. [INFOTRIEVE] [CSA]
22. Nakae, H and Endo, S and Inada, K and Takakuwa, T and Kasai, T and Yoshida, M. (1994) Serum complement levels and severity of sepsis Res Commun Chem Pathol Pharmacol, 84, pp. 189-195. [INFOTRIEVE] [CSA]
23. Nakae, H and Endo, S and Inada, K and Yoshida, M. (1996) Chronological changes in the complement system in sepsis Surg Today, 26, pp. 225-229. [INFOTRIEVE] [CSA] [CROSSREF]
24. Stove, S and Welte, T and Wagner, T and et al. (1996) Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome Clin Diagn Lab Immunol, 3, pp. 175-183. [INFOTRIEVE] [CSA]
25. Hack, C and Nuijens, J and Felt-Bersma, R and et al. (1989) Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis Am J Med, 86, pp. 20-26. [INFOTRIEVE] [CSA] [CROSSREF]
26. Gardinali, M and Padalino, P and Vesconi, S and et al. (1992) Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease Arch Surg, 127, pp. 1219-1224. [INFOTRIEVE] [CSA]
27. Horstick, G and Kempf, T and Lauterbach, M and et al. (2001) C1-esterase-inhibitor treatment at early reperfusion of hemorrhagic shock reduces mesentry leukocyte adhesion and rolling Microcirculation, 8, pp. 427-433. [INFOTRIEVE] [CSA] [CROSSREF]
28. Giebler, R and Schmidt, U and Koch, S and Peters, J and Scherer, R. (1999) Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin Crit Care Med, 27, pp. 597-604. [INFOTRIEVE] [CSA] [CROSSREF]
29. Fischer, M and Prodeus, A and Nicholson-Weller, A and et al. (1997) Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement J Immunol, 159, pp. 976-982. [INFOTRIEVE] [CSA]
30. Zeerleder, S and Caliezi, C and van Mierlo, G and et al. (2003) Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis Clin Diagn Lab Immunol, 10, pp. 529-535. [INFOTRIEVE] [CSA] [CROSSREF]
31. Caliezi, C and Zeerleder, S and Redondo, M and et al. (2002) C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction Crit Care Med, 30, pp. 1722-1728. [INFOTRIEVE] [CSA] [CROSSREF]
32. Kildsgaard, J and Hollmann, T and Matthews, K and Bian, K and Murad, F and Wetsel, R. (2000) Cutting edge: Targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock J Immunol, 165, pp. 5406-5409. [INFOTRIEVE] [CSA]
33. Boos, L and Szalai, A and Barnum, S. (2005) C3a expressed in the central nervous system protects against LPS-induced shock Neurosci Lett, 387, pp. 68-71. [INFOTRIEVE] [CSA]
34. Sacks, T and Moldow, C and Craddock, P and Bowers, T and Jacob, H. (1978) Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage J Clin Invest, 61, pp. 1161-1167. [INFOTRIEVE] [CSA]
35. Shin, H and Snyderman, R and Friedman, E and Mellors, A and Mayer, M. (1968) Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement Science, 162, pp. 361-363. [INFOTRIEVE] [CSA]
36. Goldstein, I and Weissmann, G. (1974) Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes J Immunol, 113, pp. 1583-1588. [INFOTRIEVE] [CSA]
37. Schumacher, W and Fantone, J and Kunkel, S and Webb, R and Lucchesi, B. (1991) The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo Agents Actions, 34, pp. 345-349. [INFOTRIEVE] [CSA] [CROSSREF]
38. Chenoweth, D and Hugli, T. (1978) Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes Proc Natl Acad Sci USA, 75, pp. 3943-3947. [INFOTRIEVE] [CSA] [CROSSREF]
39. Gerard, N and Gerard, C. (1991) The chemotactic receptor for human C5a anaphylatoxin Nature, 349, pp. 614-617. [INFOTRIEVE] [CSA] [CROSSREF]
40. Fureder, W and Agis, H and Willheim, M and et al. (1995) Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells J Immunol, 155, pp. 3152-3160. [INFOTRIEVE] [CSA]
41. Zwirner, J and Gotze, O and Begemann, G and Kapp, A and Kirchhoff, K and Werfel, T. (1999) Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies Immunology, 97, pp. 166-172. [INFOTRIEVE] [CSA] [CROSSREF]
42. Osaka, H and McGinty, A and Hoepken, U and Lu, B and Gerard, C and Pasinetti, G. (1999) Expression of C5a receptor in mouse brain: Role in signal transduction and neurodegeneration Neuroscience, 88, pp. 1073-1082. [INFOTRIEVE] [CSA] [CROSSREF]
43. Gasque, P and Singhrao, S and Neal, J and Gotze, O and Morgan, B. (1997) Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system Am J Pathol, 150, pp. 31-41. [INFOTRIEVE] [CSA]
44. Fayyazi, A and Scheel, O and Werfel, T and et al. (2000) The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells Immunology, 99, pp. 38-45. [INFOTRIEVE] [CSA] [CROSSREF]
45. Zwirner, J and Fayyazi, A and Gotze, O. (1999) Expression of the anaphylatoxin C5a receptor in non-myeloid cells Mol Immunol, 36, pp. 877-884. [INFOTRIEVE] [CSA] [CROSSREF]
46. 2+ release Lab Invest, 79, pp. 1287-1297. [INFOTRIEVE] [CSA]
47. Braun, M and Davis, A, 3rd. (1998) Cultured human glomerular mesangial cells express the C5a receptor Kidney Int, 54, pp. 1542-1549. [INFOTRIEVE] [CSA] [CROSSREF]
48. Mollison, K and Mandecki, W and Zuiderweg, E and et al. (1989) Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis Proc Natl Acad Sci USA, 86, pp. 292-296. [INFOTRIEVE] [CSA] [CROSSREF]
49. Zuiderweg, E and Nettesheim, D and Mollison, K and Carter, G. (1989) Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data Biochemistry, 28, pp. 172-185. [INFOTRIEVE] [CSA] [CROSSREF]
50. Huber-Lang, M and Sarma, J and McGuire, S and et al. (2003) Structure-function relationships of human C5a and C5aR J Immunol, 170, pp. 6115-6124. [INFOTRIEVE] [CSA]
51. Siciliano, S and Rollins, T and DeMartino, J and et al. (1994) Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors Proc Natl Acad Sci USA, 91, pp. 1214-1218. [INFOTRIEVE] [CSA] [CROSSREF]
52. Cain, S and Monk, P. (2002) The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74) J Biol Chem, 277, pp. 7165-7169. [INFOTRIEVE] [CSA]
53. Ohno, M and Hirata, T and Enomoto, M and Araki, T and Ishimaru, H and Takahashi, T. (2000) A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells Mol Immunol, 37, pp. 407-412. [INFOTRIEVE] [CSA]
54. Lee, D and George, S and Cheng, R and et al. (2001) Identification of four novel human G protein-coupled receptors expressed in the brain Brain Res Mol Brain Res, 86, pp. 13-22. [INFOTRIEVE] [CSA] [CROSSREF]
55. Kalant, D and Cain, S and Maslowska, M and Sniderman, A and Cianflone, K and Monk, P. (2003) The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein J Biol Chem, 278, pp. 11123-11129. [INFOTRIEVE] [CSA] [CROSSREF]
56. Okinaga, S and Slattery, D and Humbles, A and et al. (2003) C5L2, a nonsignaling C5A binding protein Biochemistry, 42, pp. 9406-9415. [INFOTRIEVE] [CSA] [CROSSREF]
57. Solomkin, J and Jenkins, M and Nelson, R and Chenoweth, D and Simmons, R. (1981) Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation Surgery, 90, pp. 319-327. [INFOTRIEVE] [CSA]
58. Guo, R and Riedemann, N and Bernacki, K and et al. (2003) Neutrophil C5a receptor and the outcome in a rat model of sepsis FASEB J, 17, pp. 1889-1891. [INFOTRIEVE] [CSA]
59. Furebring, M and Hakansson, L and Venge, P and Nilsson, B and Sjolin, J. (2002) Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis Crit Care, 6, pp. 363-370. [INFOTRIEVE] [CSA] [CROSSREF]
60. Seely, A and Naud, J and Campisi, G and et al. (2002) Alteration of chemoattractant receptor expression regulates human neutrophil chemotaxis in vivo Ann Surg, 235, pp. 550-559. [INFOTRIEVE] [CSA] [CROSSREF]
61. Strieter, R and Kasahara, K and Allen, R and et al. (1992) Cytokine-induced neutrophil-derived interleukin-8 Am J Pathol, 141, pp. 397-407. [INFOTRIEVE] [CSA]
62. Hopken, U and Mohr, M and Struber, A and et al. (1996) Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies Eur J Immunol, 26, pp. 1103-1109. [INFOTRIEVE] [CSA]
63. Laudes, I and Chu, J and Huber-Lang, M and et al. (2002) Expression and function of C5a receptor in mouse microvascular endothelial cells J Immunol, 169, pp. 5962-5970. [INFOTRIEVE] [CSA]
64. Riedemann, N and Guo, R and Sarma, V and et al. (2002) Expression and function of the C5a receptor in rat alveolar epithelial cells J Immunol, 168, pp. 1919-1925. [INFOTRIEVE] [CSA]
65. Monsinjon, T and Gasque, P and Chan, P and Ischenko, A and Brady, J and Fontaine, M. (2003) Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells FASEB J, 17, pp. 1003-1014. [INFOTRIEVE] [CSA] [CROSSREF]
66. Riedemann, N and Guo, R and Neff, T and et al. (2002) Increased C5a receptor expression in sepsis J Clin Invest, 110, pp. 101-108. [INFOTRIEVE] [CSA] [CROSSREF]
67. Fukuoka, Y and Strainic, M and Medof, M. (2003) Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a Clin Exp Immunol, 131, pp. 248-253. [INFOTRIEVE] [CSA] [CROSSREF]
68. Huber-Lang, M and Sarma, J and Rittirsch, D and et al. (2005) Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans J Immunol, 174, pp. 1104-1110. [INFOTRIEVE] [CSA]
69. Gao, H and Neff, T and Guo, R and et al. (2005) Evidence for a functional role of the second C5a receptor C5L2 FASEB J, 19, pp. 1003-1005. [INFOTRIEVE] [CSA]
70. Huber-Lang, M and Younkin, E and Sarma, J and et al. (2002) Complement-induced impairment of innate immunity during sepsis J Immunol, 169, pp. 3223-3231. [INFOTRIEVE] [CSA]
71. Zaitsu, M and Hamasaki, Y and Matsuo, M and et al. (2000) New induction of leukotriene A(4) hydrolase by interleukin-4 and interleukin-13 in human polymorphonuclear leukocytes Blood, 96, pp. 601-609. [INFOTRIEVE] [CSA]
72. Guo, R and Riedemann, N and Ward, P. (2004) Role of C5a-C5aR interaction in sepsis Shock, 21, pp. 1-7. [INFOTRIEVE] [CSA] [CROSSREF]
73. Reinhart, K and Bloos, F and Brunkhorst, F.(2005) Pathophysiology of Sepsis and Multiple Organ Dysfunction, 5th ed. Philadelphia: Elsevier.
74. Bone, R and Grodzin, C and Balk, R. (1997) Sepsis: A new hypothesis for pathogenesis of the disease process Chest, 112, pp. 235-243. [INFOTRIEVE] [CSA]
75. Levy, M and Fink, M and Marshall, J and et al. (2003). SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference 2001. In [pp. 1250-1256]. Crit Care Med
76. Goya, T and Morisaki, T and Torisu, M. (1994) Immunologic assessment of host defense impairment in patients with septic multiple organ failure: Relationship between complement activation and changes in neutrophil function Surgery, 115, pp. 145-155. [INFOTRIEVE] [CSA]
77. Niederbichler, A and Hoesel, L and Westfall, M and et al. (2006) An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction J Exp Med, 203, pp. 53-61. [INFOTRIEVE] [CSA] [CROSSREF]
78. Roumen, R and Redl, H and Schlag, G and et al. (1995) Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma Crit Care Med, 23, pp. 474-480. [INFOTRIEVE] [CSA] [CROSSREF]
79. Bengtson, A and Heideman, M. (1988) Anaphylatoxin formation in sepsis Arch Surg, 123, pp. 645-649. [INFOTRIEVE] [CSA]
80. Heideman, M and Norder-Hansson, B and Bengtson, A and Mollnes, T. (1988) Terminal complement complexes and anaphylatoxins in septic and ischemic patients Arch Surg, 123, pp. 188-192. [INFOTRIEVE] [CSA]
81. Bengtson, A and Haljamae, H. (1988) Complement activation and organ function in critically ill surgical patients Acute Care, 14-15, pp. 111-137. [CSA]
82. Zimmermann, T and Laszik, Z and Nagy, S and Kaszaki, J and Joo, F. (1989) The role of the complement system in the pathogenesis of multiple organ failure in shock Prog Clin Biol Res, 308, pp. 291-297. [INFOTRIEVE] [CSA]
83. Helliwell, T and Wilkinson, A and Griffiths, R and Palmer, T and McClelland, P and Bone, J. (1998) Microvascular endothelial activation in the skeletal muscles of patients with multiple organ failure J Neurol Sci, 154, pp. 26-34. [INFOTRIEVE] [CSA] [CROSSREF]
84. Bengtson, A and Heideman, M. (1986) Altered anaphylatoxin activity during induced hypoperfusion in acute and elective abdominal aortic surgery J Trauma, 26, pp. 631-637. [INFOTRIEVE] [CSA]
85. Heideman, M and Hugli, T. (1984) Anaphylatoxin generation in multisystem organ failure J Trauma, 24, pp. 1038-1043. [INFOTRIEVE] [CSA]
86. Seghaye, M and Duchateau, J and Grabitz, R and et al. (1993) Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure J Thorac Cardiovasc Surg, 106, pp. 978-987. [INFOTRIEVE] [CSA]
87. Slutsky, A. (2002) Hot new therapy for sepsis and the acute respiratory distress syndrome J Clin Invest, 110, pp. 737-739. [INFOTRIEVE] [CSA] [CROSSREF]